Evidence map›Paper›PMID 41642785›Full record

ArticlePloS one2026

High-quality histochemistry, immunohistochemistry, and immunofluorescence on xylene- and formalin-free paraffin-embedded tissues.

Maarten Niemantsverdriet, Anne Mei Eshuis, Naomi van der Horst, Rory Ogink, Pien van Smeerdijk, Jose van der Starre-Gaal, Agnes Marije Hoogland

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maarten NiemantsverdrietIsala pathology, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.
Anne Mei EshuisIsala pathology, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.
Naomi van der HorstIsala pathology, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.
Rory OginkIsala pathology, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.
Pien van SmeerdijkIsala pathology, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.
Jose van der Starre-GaalIsala pathology, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.
Agnes Marije HooglandIsala pathology, Dr. Van Heesweg 2, 8025 AB Zwolle, The Netherlands.ORCID https://orcid.org/0000-0001-7630-6039

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathology is a vital part of modern medicine, playing an essential role in disease diagnosis, prognosis, and therapy choice. The field of pathology depends on traditional tissue embedding techniques, still routinely using toxic and even carcinogenic substances to process tissues for diagnostics. Chronic exposure of humans to xylene and/or formalin, two essential components in the process, may result in severe health problems. Accumulating insights resulted in a ban of formalin in Europe for multiple applications and tight restrictions for almost all other uses since its toxicity levels were upgraded to carcinogen grade 1B and mutagen grade 2. A remarkable exception to these regulations is the use of formalin in the field of pathology, because of the existing lack of formalin-free tissue embedding methods that produce high-quality pathology specimens. Here we show that a novel embedding technique employing supercritical Carbon dioxide (CO2), used in a xylene- and formalin-free manner, results in high-quality tissue samples, suitable for the fundamental techniques used in pathology: histochemistry, immunohistochemistry, and immunofluorescence.

Indexed as

Fluorescent Antibody TechniqueHistocytochemistryImmunohistochemistryParaffin EmbeddingXylenesAnimalsFormaldehydeHumansTissue FixationFormaldehydeXylenes

Identifiers

PMID41642785
PMCPMC12875444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.